SkinBioTherapeutics (GB:SBTX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
SkinBioTherapeutics, a life science company, has issued 2,349,624 new ordinary shares, boosting its total to 228,435,909 shares, as it prepares for trading on the AIM Market of the London Stock Exchange. This move reflects the company’s ongoing efforts to expand its investment base and strengthen its position in the skin health sector.
For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.
